Patients with chronic conditions, such as chronic obstructive pulmonary disease, often have high-cost health needs that make choosing a health plan difficult.
Patients with chronic conditions, such as chronic obstructive pulmonary disease (COPD), often have high-cost health needs that make choosing a health plan difficult. A new infographic from the American Lung Association (ALA) can guide patients with COPD through the process of choosing a health plan through the Affordable Care Act (ACA)’s exchanges.
Harold P. Wimmer, national president and CEO of the American Lung Association (ALA), explained that patients with chronic diseases may not be aware of what their out-of-pocket costs will be, and as a result are not selecting the best health insurance for their individual circumstances.
"There is a lot to consider when choosing a health plan," Wimmer said in a statement. "Through this resource, we hope to help consumers better understand how to make the best choice, and pick a plan that is likely to result in the lowest out-of-pocket costs to the patient."
He added that having access to care doesn’t mean patients with COPD will necessarily be able to afford it. These patients need to keep in mind premium, deductible, and co-payments, as well as any other factors that can affect their yearly out-of-pocket costs. In addition, the ALA reminds COPD patients to check plans’ coverage for doctors and specialists, hospitals and medications.
As patients with COPD who have high-cost health needs choose their health plans—with the deadline January 31, 2016—they should keep in mind that they are likely to reach the maximum out of pocket expenses, which they can add to premiums to estimate their total yearly costs.
"This is important information because we know patients may put off care to avoid co-payments or other out-of-pocket expenses that may lead to worse health outcomes," Wimmer said. "Without this analysis, patients may not be able to accurately estimate their costs and utilization of healthcare services to pick the best plan for their circumstances."
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
An Overview of Health Care and Pharmaceutical Trends, 2023-2024
April 19th 2024Douglas M. Long, BA, MBA, was featured as the keynote speaker on the closing day of The Academy of Managed Care Pharmacy 2024 annual meeting, with a session dedicated to surveying the health care and pharmaceutical trends of the last year.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Real-World Study Reveals Key Insights Into DLBCL Treatment Patterns, Outcomes
April 18th 2024A recent study offers valuable insights into the characteristics, treatment patterns, and outcomes of diffuse large B-cell lymphoma (DLBCL) in patients across different lines of therapy, providing a look into the landscape of DLBCL management.
Read More